<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592485</url>
  </required_header>
  <id_info>
    <org_study_id>KE-0254/127/2018</org_study_id>
    <nct_id>NCT03592485</nct_id>
  </id_info>
  <brief_title>ESP vs ESP With PECS</brief_title>
  <official_title>Efficacy of Erector Spinae Plane Block and Pectoral Fascia Block in Patients Undergoing Mitral Valve Repair Through the Right Mini-thoracotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszów, Poland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients scheduled for minimally invasive mitral valve repair. Each patient will be treated
      with intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be
      allocated to one of the groups: erector spinae plane (ESP) block or EPS with pectoral fascia
      (PECS) block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Only patients who are qualified for an elective procedure of mitral valve replacement may
      participate in the study. Each patient will be anesthetized generally. The same drugs will be
      used in each stage of anesthesia. The induction: etomidate, remifentanil, rocuronium, scolina
      as required. The maintenance: sevoflurane, remifentanil, rocuronium. The emergence: oxygen,
      sugammadex or neostigmine a required.

      Patients will be randomly allocated to one of two groups: ESP or PECS. Among the patients
      from ESP group will have ESP blockade before the induction of general anesthesia. ESP
      blockade will be performed under ultrasound control. A single-shot technique will be used
      with 0.375 % solution of ropivacaine: 0.1 mL per patient KG. The maximum dose is 20 mL.

      Patients from PECS group will receive ESP block and PECS I and II type block with 0.375 %
      solution of ropivacaine (up to 20 mL of local anesthetic).

      Each patient, before the end of surgery, will be administered i.v. 0.1 mg of oxycodone. PCA
      with oxycodone (1mg/mL) will be utilized during the postoperative period: 7-minute interval.
      This is standard protocol in the investigator's department.

      Only patients who are successfully awakened after the procedure may participate in the study.

      The pain intensity will be assessed with visual-analogue scale (VAS) at 2, 4, 8, 12 and 24
      hour after the end of anesthesia.

      The total consumption of oxycodone will be also monitored.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 28, 2018</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single (Participant)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total consumption of oxycodone</measure>
    <time_frame>From the end of anesthesia till 24 hour postoperatively</time_frame>
    <description>The cumulative consumption of oxycodone during 24 hour from the end of anesthesia. Less is better, less intense pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity measured by VAS</measure>
    <time_frame>From the end of anesthesia till 24 hour postoperatively</time_frame>
    <description>Patient self-pain assessment on VAS (visual-analogue scale). VAS range from 0 (no pain, good outcome) to 100 in millimeters (the worst pain ever, bad outcome)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Mitral Valve Disease</condition>
  <arm_group>
    <arm_group_label>ESP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Before the induction of general anesthesia, Erector Spinae Plane (ESP) blockade will be done. Postoperative analgesia is provided with intravenous oxycodone. Patient-controlled analgesia pump (PCA) will be used for this purpose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PECS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Before the induction of general anesthesia, Erector Spinae Plane (ESP) block and Pectoral fascia type I and II will be done. Postoperative analgesia is provided with intravenous oxycodone. Patient-controlled analgesia pump (PCA) will be used for this purpose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector Spinae Plane blockade</intervention_name>
    <description>Before the beginning of the procedure, ESP blockade will be performed under ultrasound control. A single-shot technique will be used with 0.375 % solution of ropivacaine: 0.1 mL per patients' KG. The maximum dose is 20 mL.</description>
    <arm_group_label>ESP</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pectoral Fascia block</intervention_name>
    <description>Before the beginning of the procedure, PECS type I and II blocks will be performed under ultrasound control. A single-shot technique will be used with 0.375 % solution of ropivacaine: 0.1 mL per patients' KG. The maximum dose is 20 mL.</description>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>Each patient, before the end of surgery, will be administered i.v. 0.1 mg of oxycodone. PCA with oxycodone (1mg/mL) will be utilized during the postoperative period: 5-minute interval.</description>
    <arm_group_label>ESP</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>general anesthesia</intervention_name>
    <description>Each patient will generally anesthetized and endotracheal tube will be inserted</description>
    <arm_group_label>ESP</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
    <other_name>GA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>Paracetamol will be given i.v. every 6 hours.</description>
    <arm_group_label>ESP</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled mitral valve replacement surgery

          -  obtained consent

        Exclusion Criteria:

          -  allergy to oxycodone and local anesthetics

          -  depression, antidepressant drugs treatment

          -  epilepsy

          -  usage of painkiller before surgery

          -  addiction to alcohol or recreational drugs

          -  prolonged postoperative ventilation (over 2 hours)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszów, Poland</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>February 27, 2019</last_update_submitted>
  <last_update_submitted_qc>February 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Michał Borys</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Erector Spinae Plane blockade</keyword>
  <keyword>Pectoral Fascia block</keyword>
  <keyword>patient control anlagesia</keyword>
  <keyword>mitral valve replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

